"Methods And Compositions For Generating Stem Cell-Derived Immune Cells With Enhanced Function" in Patent Application Approval Process (USPTO 20240117311).
In: Stem Cell Week, 2024-05-02, S. 633-633
serialPeriodical
Zugriff:
The patent application titled "Methods And Compositions For Generating Stem Cell-Derived Immune Cells With Enhanced Function" discusses the potential of immune cells in cancer treatment and proposes a method of generating stem cell-derived immune cells with enhanced function. The method involves modifying stem cells to inhibit the function of certain target genes, resulting in immune cells that retain the gene inhibition and exhibit improved activity. These modified cells can be derived from various types of stem cells and can be further modified to express a chimeric antigen receptor (CAR). The patent application provides detailed claims and descriptions of the methods and compositions, which may have potential applications in treating conditions such as cancer, infections, autoimmune disorders, fibrosis, and endometriosis. [Extracted from the article]
Copyright of Stem Cell Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
"Methods And Compositions For Generating Stem Cell-Derived Immune Cells With Enhanced Function" in Patent Application Approval Process (USPTO 20240117311).
|
---|---|
Zeitschrift: | Stem Cell Week, 2024-05-02, S. 633-633 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1537-1360 (print) |
Schlagwort: |
|
Sonstiges: |
|